# | Drug | Count |
---|---|---|
0 | OXALIPLATIN | 75 |
1 | CAPECITABINE | 39 |
2 | FLUOROURACIL | 15 |
3 | BEVACIZUMAB | 13 |
4 | DEXAMETHASONE | 11 |
5 | DEXAMETHASONE 1.5 MG | 11 |
6 | METFORMIN | 6 |
7 | METFORMIN ER 500 MG | 6 |
8 | METFORMIN ER 750 MG | 6 |
9 | PANTOPRAZOLE | 6 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | OXALIPLATIN | 75 | 0.0017 |
1 | MITOMYCIN | 3 | 0.0014 |
2 | TERBUTALINE SULFATE | 1 | 0.0008 |
3 | CAPECITABINE | 39 | 0.0006 |
4 | GRANISETRON HYDROCHLORIDE | 3 | 0.0004 |
5 | GRANISETRON | 3 | 0.0004 |
6 | FLUOROURACIL | 15 | 0.0003 |
7 | MARC GLASSMAN | 1 | 0.0003 |
8 | CALCIUM GLUCONATE | 2 | 0.0002 |
9 | FLUVASTATIN SODIUM | 1 | 0.0002 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Platinum-based Drug [EPC] | 77 | 0.0005 |
1 | Nucleoside Metabolic Inhibitor [EPC] | 53 | 0.0003 |
2 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 14 | 0.0001 |
4 | Serotonin-3 Receptor Antagonist [EPC] | 5 | 0.0001 |
5 | Phenothiazine [EPC] | 1 | 0.0001 |
6 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
7 | Prostaglandin Analog [EPC] | 2 | 0.0000 |
8 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 1 | 0.0000 |
9 | l-Thyroxine [EPC] | 3 | 0.0000 |